I Y Gluzman

Plasmodium falciparum maturation abolishes physiologic red cell deformability.

I. Gluzman, J. Williamson, S. Sutera, 1984, Science.

Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.

I. Gluzman, D. Goldberg, K. Duffin, 1994, The Journal of clinical investigation.

Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.

I D Kuntz, A G Skillman, T J Ewing, 1999, Journal of medicinal chemistry.

Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.

I. Gluzman, D. Goldberg, M. Orlowski, 1998, Bioorganic & medicinal chemistry letters.

Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

R E Cachau, P. Collins, T. Bhat, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D.

I. Gluzman, D. Goldberg, M. Orlowski, 1998, Bioorganic & medicinal chemistry letters.